REGENERON PHARMACEUTICALS, INC.
ent_019ed39d466aa6ae13f436aa150aa062
Disclosures
4
State AG · 4 jurisdictions
Multi-filing incidents
1
incidents joining 2+ filings here
Max affected reported
23,303
as filed · State AG IN
Leak-site claims
0
none in sample
Identity resolution
- Canonical name
- REGENERON PHARMACEUTICALS, INC.
- Normalized
- regeneron pharmaceuticals— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- 549300RCBFWIRX3HYQ56
- SEC EDGAR CIK
- 0000872589
- Domain
- None on record
Disclosure history (4)newest first
- Washington State AGas victim2024-05-22
Regeneron Pharmaceuticals, Inc. experienced a data breach via its third-party vendor, The Lash Group, LLC. Unauthorized access occurred on Feb 21, 2024, involving exfiltration of PII and PHI (names, DOB, addresses, health diagnoses, prescriptions) from ~13,958 individuals. Lash Group detected the breach on Feb 21, 2024, and Regeneron was notified on April 18, 2024. Notifications were sent in May 2024.
- Indiana State AGas victim2024-05-22
Regenoeron Pharmaceuticals Inc reported a data breach to the Indiana Attorney General. The breach occurred on 2024-02-21 and was reported on 2024-05-22. 23,303 Indiana residents were affected.
- Montana State AGas reporting2024-05-22
Cencora, Inc. notified Montana residents of a data security incident involving its Lash Group affiliate. On Feb 21, 2024, Cencora learned that data from its information systems had been exfiltrated. The incident potentially affected personal information including names, addresses, dates of birth, health diagnoses, and medications. Cencora engaged law enforcement and cybersecurity experts, and is offering 24 months of credit monitoring.
- Massachusetts State AGas victim2010-07-27
Regeneron Pharmaceuticals, Inc. reported a data breach to the Massachusetts Office of Consumer Affairs and Business Regulation. The breach was reported on 2010-07-27. 41 Massachusetts residents were affected. The report records the breach type as electronic.